Should I buy or sell Establishment Labs stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares. View ESTA analyst ratings or view top-rated stocks .

What is Establishment Labs' stock price target for 2024?

5 analysts have issued 1-year price targets for Establishment Labs' stock. Their ESTA share price targets range from $47.00 to $65.00. On average, they predict the company's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 16.1% from the stock's current price. View analysts price targets for ESTA or view top-rated stocks among Wall Street analysts .

How have ESTA shares performed in 2024?

Establishment Labs' stock was trading at $25.89 at the beginning of the year. Since then, ESTA stock has increased by 83.0% and is now trading at $47.38. View the best growth stocks for 2024 here .

Are investors shorting Establishment Labs?

Establishment Labs saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,930,000 shares, an increase of 8.1% from the March 15th total of 4,560,000 shares. Based on an average daily volume of 457,400 shares, the short-interest ratio is presently 10.8 days. Currently, 21.7% of the company's shares are sold short. View Establishment Labs' Short Interest .

When is Establishment Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our ESTA earnings forecast .

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.79) EPS for the quarter, topping the consensus estimate of ($0.95) by $0.16. The business had revenue of $31.60 million for the quarter, compared to the consensus estimate of $31.44 million. Establishment Labs had a negative trailing twelve-month return on equity of 357.81% and a negative net margin of 47.53%. Establishment Labs's revenue for the quarter was down 27.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.55) earnings per share.

What ETFs hold Establishment Labs' stock?

ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK) . First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) .

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $174.0 million-$184.0 million, compared to the consensus revenue estimate of $173.7 million.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV) , Enterprise Products Partners (EPD) , Sientra (SIEN) , Allergan (AGN) , BCE (BCE) , Canadian Imperial Bank of Commerce (CM) , Canadian Natural Resources (CNQ) , Chevron (CVX) and Evolus (EOLS) .

When did Establishment Labs IPO?

Establishment Labs (ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by a variety of retail and institutional investors. Top institutional investors include Stableford Capital II LLC (0.11%). Insiders that own company stock include Dennis E Condon, Dennis E Condon , Edward J Schutter , Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh , Mezerville Roberto De , Nicholas Sheridan Lewin , Raj Denhoy and Renee Gaeta . View institutional ownership trends .

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ESTA

Establishment Labs (ESTA) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free ESTA Stock Alerts

$47.38

-5.19 (-9.87%)

(As of 04/19/2024 ET)

Compare

Today's Range: $47.07
▼
$52.60
50-Day Range: $35.80
▼
$55.38
52-Week Range: $16.96
▼
$77.55

Volume: 427,159 shs
Average Volume: 432,340 shs
Market Capitalization: $1.30 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $55.00

Get Establishment Labs alerts:

Establishment Labs MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 16.1% Upside
$55.00 Price Target
Short Interest: Bearish
21.72% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.70
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.58) to ($0.48) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.76 out of 5 stars

Medical Sector

837th out of 911 stocks

Surgical Appliances & Supplies Industry

18th out of 18 stocks

2.5

Analyst's Opinion

Consensus Rating
Establishment Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Establishment Labs has only been the subject of 3 research reports in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
21.72% of the float of Establishment Labs has been sold short.
Short Interest Ratio / Days to Cover
Establishment Labs has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
Change versus previous month
Short interest in Establishment Labs has recently increased by 8.11%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Establishment Labs does not currently pay a dividend.
Dividend Growth
Establishment Labs does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ESTA.

2.6

News and Social Media Coverage

News Sentiment
Establishment Labs has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Establishment Labs this week, compared to 3 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Establishment Labs insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.64% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Establishment Labs are expected to grow in the coming year, from ($1.58) to ($0.48) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Establishment Labs is -15.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Establishment Labs is -15.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Establishment Labs has a P/B Ratio of 66.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Establishment Labs Stock (NASDAQ:ESTA)

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

ESTA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ESTA Stock News Headlines

April 17, 2024 | msn.com

Establishment Labs Holdings (ESTA) Price Target Increased by 10.70% to 61.54

April 17, 2024 | finance.yahoo.com

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 17, 2024 | businesswire.com

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

April 16, 2024 | msn.com

NPR suspends editor who claimed left-wing bias at outlet had ‘lost America’s trust’

April 12, 2024 | msn.com

UMass Chan unveils first lab to monitor AI use in health care simulations

April 12, 2024 | americanbankingnews.com

Establishment Labs (NASDAQ:ESTA) Shares Gap Down to $55.38

April 10, 2024 | finance.yahoo.com

Lab-Grown Diamonds Market Set for Explosive Growth - The Future is Here

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 10, 2024 | msn.com

'Mini kidneys' reveal new insights into metabolic defects in polycystic kidney disease

April 10, 2024 | msn.com

Beach Haven kidnapping: Police raid Clevedon property looking for Ralph Park, find clandestine drug lab

April 4, 2024 | msn.com

Centre’s law to regulate labs to remain in force, HC told

April 4, 2024 | msn.com

HC happy over Delhi govt’s decision to implement Centre’s law to regulate clinical establishments

April 3, 2024 | msn.com

New Mexico chefs, food establishments named as 2024 James Beard Award finalists

April 3, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)

April 1, 2024 | markets.businessinsider.com

Key Takeaways From Establishment Labs Hldgs Analyst Ratings

April 1, 2024 | tmcnet.com

Deepcoin Labs Will Be Sponsoring Hong Kong Web3 Festival 2024

March 29, 2024 | finance.yahoo.com

Moomoo Announces the Moomoo Foundation Establishment, Hosts Financial Literacy Event with NYU's Economic Society

March 29, 2024 | news.yahoo.com

Ohio's first infused coffee shop lounge opens in Dayton

March 20, 2024 | markets.businessinsider.com

Establishment Labs Poised for Robust Growth with Motiva Expansion and Upcoming Market Entries

March 15, 2024 | markets.businessinsider.com

BNB Chain Looks to Expand L2 Ecosystem; Introduces RaaS to Streamline Establishment of New L2 Blockchains

March 12, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness

March 12, 2024 | msn.com

Union Minister Rajeev Chandrasekhar Announces 10 AI Labs in Thiruvananthapuram Constituency

March 12, 2024 | msn.com

10 AI labs in Thiruvananthapuram colleges to establish soon

March 12, 2024 | msn.com

Rajeev Chandrasekhar announces 10 AI labs in Thiruvananthapuram colleges

March 2, 2024 | finance.yahoo.com

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Analysts Are Pretty Bullish On The Stock After Recent Results

February 29, 2024 | finance.yahoo.com

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2023 Earnings Call Transcript

See More Headlines

Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:ESTA
CUSIP: N/A
CIK: 1688757
Web: www.establishmentlabs.com
Phone: (062) 434-2400
Fax: N/A
Employees: 908
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $55.00
High Stock Price Target: $65.00
Low Stock Price Target: $47.00
Potential Upside/Downside: +4.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-78,500,000.00
Net Margins: -47.53%
Pretax Margin: -47.58%
Return on Equity: -357.81%
Return on Assets: -30.37%

Debt

Debt-to-Equity Ratio: 10.26
Current Ratio: 3.06
Quick Ratio: 1.67

Sales & Book Value

Annual Sales: $165.15 million
Price / Sales: 8.74
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.71 per share
Price / Book: 74.04

Miscellaneous

Outstanding Shares: 27,460,000
Free Float: 23,989,000
Market Cap: $1.44 billion
Optionable: Optionable
Beta: 1.24

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Juan Jose Chacon Quiros (Age 52)
Founder, CEO & Executive Director
Comp: $913.37k
Mr. Rajbir Singh Denhoy (Age 54)
Chief Financial Officer
Comp: $570.29k
Mr. S. Ross Mansbach (Age 57)
General Counsel & Chief Compliance Officer
Comp: $379.53k
Mr. Roberto de Mezerville (Age 43)
Chief Technology Officer
Mr. Salvador Santos Dada (Age 42)
Head of Special Projects
Comp: $468.62k
Ms. Rosalyn Cole d'Incelli
SVP of Global Clinical, Medical & US Regulatory Affairs
Ms. Elizabeth Panzica Newman
VP & Head of U.S Business Unit
Mr. Ivan Bilic
Senior Vice President of Commercial Operations - OUS
Ms. Neeta Toprani
Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ESTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Establishment Labs stock right now?: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings or view top-rated stocks.
What is Establishment Labs' stock price target for 2024?: 5 analysts have issued 1-year price targets for Establishment Labs' stock. Their ESTA share price targets range from $47.00 to $65.00. On average, they predict the company's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 16.1% from the stock's current price.
View analysts price targets for ESTA or view top-rated stocks among Wall Street analysts.
How have ESTA shares performed in 2024?: Establishment Labs' stock was trading at $25.89 at the beginning of the year. Since then, ESTA stock has increased by 83.0% and is now trading at $47.38.
View the best growth stocks for 2024 here.
Are investors shorting Establishment Labs?: Establishment Labs saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,930,000 shares, an increase of 8.1% from the March 15th total of 4,560,000 shares. Based on an average daily volume of 457,400 shares, the short-interest ratio is presently 10.8 days. Currently, 21.7% of the company's shares are sold short.
View Establishment Labs' Short Interest.
When is Establishment Labs' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our ESTA earnings forecast.
How were Establishment Labs' earnings last quarter?: Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.79) EPS for the quarter, topping the consensus estimate of ($0.95) by $0.16. The business had revenue of $31.60 million for the quarter, compared to the consensus estimate of $31.44 million. Establishment Labs had a negative trailing twelve-month return on equity of 357.81% and a negative net margin of 47.53%. Establishment Labs's revenue for the quarter was down 27.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.55) earnings per share.

What ETFs hold Establishment Labs' stock?: ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).
What guidance has Establishment Labs issued on next quarter's earnings?: Establishment Labs issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $174.0 million-$184.0 million, compared to the consensus revenue estimate of $173.7 million.
What other stocks do shareholders of Establishment Labs own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).
When did Establishment Labs IPO?: Establishment Labs (ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.
Who are Establishment Labs' major shareholders?: Establishment Labs' stock is owned by a variety of retail and institutional investors. Top institutional investors include Stableford Capital II LLC (0.11%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Raj Denhoy and Renee Gaeta.
View institutional ownership trends.
How do I buy shares of Establishment Labs?: Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ESTA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Establishment Labs (ESTA) Stock Price, News & Analysis

Establishment Labs MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Establishment Labs Stock (NASDAQ:ESTA)

ESTA Stock Price History

ESTA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

ESTA Stock Analysis - Frequently Asked Questions

Overall MarketRank^™